Prodrugs of CL316243: a selective β3-adrenergic receptor agonist for treating obesity and diabetes
F. W. Sum(Pearl River Community College), K. Steiner(Pearl River Community College), Michael S. Malamas(Pearl River Community College), Z. Chen(Pearl River Community College), Iwan Gunawan(Pearl River Community College), Aradhana M. Venkatesan(National Institutes of Health), Elwood Largis(Pearl River Community College), G Grosu(Pearl River Community College), Malikah O’Dell(Pearl River Community College), Kyungjae Lim(Pearl River Community College), Victoria Wong(Pearl River Community College), J. L. PRIMEAU(Pearl River Community College), A. Gilbert(Pearl River Community College), Gerardo D. Francisco(Pearl River Community College), Jillian G. Baker(Nottingham University Hospitals NHS Trust), John W. Ellingboe(Pearl River Community College)
Cited by 25
Related Papers
Structure of a β1-adrenergic G-protein-coupled receptor
|Nature|2008|1.3k
Tremelimumab in combination with ablation in patients with advanced hepatocellular carcinoma
|Journal of Hepatology|2016|817
The structural basis for agonist and partial agonist action on a β1-adrenergic receptor
|Nature|2011|623
The selectivity of β‐adrenoceptor agonists at human β<sub>1</sub>‐, β<sub>2</sub>‐ and β<sub>3</sub>‐adrenoceptors
|British Journal of Pharmacology|2010|586
The selectivity of <i>β</i>‐adrenoceptor antagonists at the human <i>β</i>1, <i>β</i>2 and <i>β</i>3 adrenoceptors
|British Journal of Pharmacology|2005|535